other material
confidence high
sentiment negative
materiality 0.75
Aterian, Inc. (ATER): Nasdaq/NYSE listing notice — Aterian receives Nasdaq minimum bid price deficiency notice; 180 days to cure
Aterian, Inc.
- Nasdaq notified Aterian on April 24, 2023 that its common stock bid price was below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until October 23, 2023, to regain compliance with Nasdaq Listing Rule 5550(a)(2).
- To regain compliance, closing bid price must be at or above $1.00 for at least 10 consecutive business days.
- If not cured by Oct 23, 2023, Nasdaq may grant a second 180-day period if other listing standards are met.
- Failure to cure could lead to delisting; Company may appeal to a Nasdaq hearings panel.